Clinical Trial Update: Novel Antineuronal Antibodies in Gastrointestinal Motility Disorders

View source ↗

Summary

Johns Hopkins University reports a clinical trial evaluating novel antineuronal antibodies for autoimmune gastrointestinal dysmotility; the study is currently a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Gastrointestinal Dysmotility

Snippet

Sponsor: Johns Hopkins University | Conditions: Autoimmune Gastrointestinal Dysmotility | Status: ACTIVE_NOT_RECRUITING